Dietary caffeine, performance and mood: Enhancing and restorative effects after controlling for withdrawal reversal

Neuropsychobiology

Volumn 52, Issue 1, 2005, Pages 1-10

  James, Jack E ^a   Gregg, M Elizabeth ^a   Kane, Marian ^a   Harte, Frances ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Caffeine; Mood; Performance; Sleep restriction; Withdrawal reversal

Indexed keywords

CAFFEINE; PLACEBO;

ABSTINENCE; ADOLESCENT; ADULT; ALERTNESS; ARTICLE; COGNITION; COMPARATIVE STUDY; DIET; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; PERFORMANCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SLEEP; TASK PERFORMANCE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AFFECT; AROUSAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SALIVA; SEX CHARACTERISTICS; SLEEP DEPRIVATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 21344447057     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086172     Document Type: Article

References (39)

1. Bonnet MH, Arand DL: Impact of naps and caffeine on extended nocturnal performance. Physiol Behav 1994;56:103-109.
2. Smith AP, Maben AL, Brockman P: The effects of caffeine and evening meals on sleep and performance, mood and cardiovascular functioning the following day. J Psychopharmacol 1993;7:203-206.
3. Walsh JK, Muelbach MJ, Humm TM, Dickens QS, Sugerman JL: Effect of caffeine on physiological sleep tendency and ability to sustain wakefulness at night. Psychopharmacology 1990;101:271-273.
4. Reyner LA, Horne JA: Efficacy of a 'functional energy drink' in counteracting driver sleepiness. Physiol Behav 2002;75:331-335.
5. James JE: Caffeine and psychomotor performance revisited. Neuropsychobiology 1995;31:202-203.
6. James JE: Understanding Caffeine: A Biobehavioral Analysis. Thousand Oaks, Sage, 1997.
7. James JE: Acute and chronic effects of caffeine on performance, mood, headache, and sleep. Neuropsychobiology 1998;38:32-41.
8. Smith AP: Caffeine, caffeine withdrawal and psychomotor performance: A reply to James. Neuropsychobiology 1995;31:200-201.
9. Smith AP, Clark R, Gallagher J: Breakfast cereal and caffeinated coffee: Effects on working memory, attention, mood, and cardiovascular function. Physiol Behav 1999;67:9-17.
10. Warburton DM, Bersellini E, Sweeney E: An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology 2001;158:322-328.
11. Yeomans MR, Ripley T, Davies LH, Rusted JM, Rogers PJ: Effects of caffeine on performance and mood depend on the level of caffeine abstinence. Psychopharmacology 2002;164:241-249.
12. James JE: Does caffeine enhance or merely restore degraded psychomotor performance? Neuropsychobiology 1994;30:124-125.
13. Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP: Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990;255:1123-1132.
14. Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ: Caffeine self-administration and withdrawal: Incidence, individual differences and interrelationships. Drug Alcohol Depend 1993;32:239-246.
15. Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG: The effects of low doses of caffeine on human performance and mood. Psychopharmacology 1987;92:308-312.
16. Smit HJ, Rogers PJ: Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology 2000;152:167-173.
17. Goldstein A, Kaizer S, Whitby O: Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther 1969;10:489-497.
18. James JE, Gregg ME: Effects of dietary caffeine on mood when rested and sleep restricted. Hum Psychopharmacol Clin Exp 2004;19:333-341.
19. Lane JD, Phillips-Bute BG: Caffeine deprivation affects vigilance performance and mood. Physiol Behav 1998;65:171-175.
20. Phillips-Bute BG, Lane JD: Caffeine withdrawal symptoms following brief caffeine deprivation. Physiol Behav 1998;63:35-39.
21. Richardson NJ, Rogers PJ, Elliman NA, O'Dell RJ: Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol Biochem Behav 1995;52:313-320.
22. Rogers PJ, Martin J, Smith C, Heatherley SV, Smit HJ: Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology 2003;167:54-62.
23. James JE: Caffeine, mental performance and mood; in Watson D (ed): Performance Functional Foods. London, Woodhead, 2003, pp 168-194.
24. James JE, Bruce MS, Lader MH, Scott NR: Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 1989;27:507-514.
25. Parsons WD, Neims MD: Effect of smoking on caffeine clearance. Clin Pharmacol Ther 1978;24:40-45.
26. Abernethy DR, Todd EL: Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 1985;28:425-428.
27. James JE: Caffeine and Health. London, Academic Press, 1991.
28. Pfeifer RW, Notari RE: Predicting caffeine plasma concentrations resulting from consumption of food or beverages: A simple method and its origin. Drug Intel Clin Pharm 1988;22:953-959.
29. Denaro C, Brown CR, Jacob P III, Benowitz NL: Effects of caffeine with repeated dosing. Eur J Clin Pharmacol 1991;403:273-278.
30. Robertson D, Wade D, Workman R, Woosley RL, Oates JA: Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981;67:1111-1117.
31. Griffiths RR, Bigelow GE, Liebson IA, O'Keeffe M, O'Leary D, Russ N: Human coffee drinking: Manipulation of concentration and caffeine dose. J Exp Anal Benav 1986;45:133-148.
32. Alkaysi HN, Shiekh Salem M, El-Sayed YM: High performance liquid chromatographic analysis of caffeine concentrations in plasma and saliva. J Clin Pharm Ther 1988;13:109-115.
33. Lelo A, Miners JO, Robson R, Birkett DJ: Assessment of caffeine exposure: Caffeine content of beverages caffeine intake and plasma concentrations of methylxanthines. Clin Pharmacol Ther 1986;39:54-59.
34. Coffield TG, Tryon W: Construct validation of actigraphic sleep measures in hospitalized depressed patients. Behav Sleep Med 2004;2;24-40.
35. Wolfson AR, Carskadon MA, Acebo C, Seifer R, Fallone G, Labyak SE, Martin JL: Evidence for the validity of a sleep habits survey for adolescents. Sleep 2003;26:213-216.
36. Green MW, Rogers PJ: Impaired cognitive functioning during spontaneous dieting. Psych Med 1995;25:1003-1010.
37. McNair PM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego, Educational and Industrial Testing Service, 1981.
38. Azcona O, Barbanoj MJ, Torrent J, Jané F: Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 1995;40:393-400.
39. McNair PM, Lorr M, Droppleman LF: Profile of Mood States: Bipolar Form. San Diego, Educational and Industrial Testing Service, 1988.